Revolutionary Blutzuckermessung: Schmerzfrei en ohne Blut!

The Zukunft der Blutzuckermessung is a revolutionary hike! People with diabetes need to have their blood sugar levels checked regularly, which is often difficult and invasive methods are recommended. The innovative technology from DiaMonTech AG dies bare. Laut einem Bericht von Transkript ermöglicht een nicht invasive Messung, die basiert auf 15 Jahren Forschung. Glue molecules at the highest temperature and beautiful gemstones were processed with an amount of laser laser. “The blutzucker mirror is a messenger that is a bit dexterous with the finger it uses. Ohne Schmerzen und ohne Blut“, explains Thorsten Lubinski, CEO of DiaMonTech.

This fast method was awarded the Health-i Award in October and can no longer be used for diabetes due to diabetes. Lubinski concretes, that is a person who makes a profit from the glucose supply on the crossings, a lonely lifestyle on the ground. The vision is the technology that will be developed in the future by integrating smartwatches, but had never been in the development stage.

The reforms of smartwatch technology

The idea of ​​a smartwatch, the blutzucker who sees it, no longer comes from reality. Dr. Stefan Pleus from the Institute for Diabetes Technology and the University of Ulm warns about the available models. “Finger away!” says an alarming test, which says that this new data is sweeter, not hanging up, but becoming a human or a banana, which is described in a message from the Pharmacy. The FDA in the US has reached an issue with the company’s results, the messages have not appeared before.

Dennoch gives a fortschritte in the Forschung. Technologies with Raman spectroscopy, the Light Pulse for Analysis of used web pages, will probably yield many promising results. If the bioelectrical impedance is interrupted, it will cause a power failure through the glucose messaging. The re-ordering is possible, the messaging will be expanded and sent, the small pleasure will be that a Smartwatch integration will be integrated.

Finanzierung und Zukunftsausblick

The DiaMonTech AG has raised 22 million euros for the company’s non-invasive method, which has delivered a factory, which will continue the latest financing round a few years later. “We could choose investors who won Samsung,” says Lubinski. The advantage is that this technology is bare for all applications and the revolutionary blutzckermessung.

It is not that the disease is in the blutzuckermessung of the diabetics as one of the healthy people of a larger bed. The combination of innovative technology and the Streben with low freedom of use can use the art and convenience, while our Blutzucker messenger works for more and more changes. The Zukunft often looks as if there are no re-enactments possible.

Ort des Geschehens

Analyze Quellen, the best report: 19
Social media comments analyzed: 99
Analysis of the analysis: 88